Maravai LifeSciences Holdings, Inc.MRVINASDAQ

Revenue (LTM)

$186M

-28.3% YoY

Net Income (LTM)

$-131M

+9.7% YoY

Free Cash Flow

$-71M

Revenue CAGR (5Y)

-8.1%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	799	883↑10.5%	289↓67.3%	259↓10.3%	186↓28.3%
Gross Profit	659	714↑8.4%	140↓80.4%	108↓22.7%	33↓69.2%
Operating Income	555	574↑3.5%	-32↓105.5%	-236↓644.5%	-7↑97.1%
Net Income	182	220↑21.0%	-119↓154.1%	-145↓21.7%	-131↑9.7%
EBITDA	586	610↑4.1%	712↑16.8%	-157↓122.0%	-147↑6.2%
EPS Diluted	1.56	1.67↑7.1%	-0.90↓153.9%	-1.05↓16.7%	-0.91↑13.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	551	632↑14.7%	575↓9.0%	322↓43.9%	217↓32.7%
Total Current Assets	740	848↑14.6%	700↓17.5%	429↓38.7%	296↓31.0%
Total Assets	1,918	2,282↑19.0%	1,487↓34.8%	1,008↓32.2%	771↓23.6%
Total Current Liabilities	94	110↑17.5%	87↓20.6%	57↓34.9%	45↓21.2%
Total Liabilities	1,373	1,377↑0.3%	698↓49.3%	431↓38.2%	398↓7.7%
Total Equity	315	545↑72.8%	417↓23.6%	325↓21.9%	212↓34.7%
Total Debt	575	585↑1.7%	611↑4.4%	377↓38.3%	36↓90.6%
Net Debt	24	-47↓295.7%	36↑176.8%	54↑50.8%	-181↓433.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	369	536↑45.4%	126↓76.4%	7↓94.1%	-58↓871.2%
Capital Expenditure	-15	-17↓15.1%	-66↓283.6%	-30↑54.8%	-13↑55.7%
Free Cash Flow	354	519↑46.7%	61↓88.3%	-22↓136.6%	-71↓218.7%
Stock-Based Comp	10	19↑78.5%	35↑85.3%	49↑42.9%	0
Net Change in Cash	315	81↓74.3%	-57↓170.7%	-253↓341.7%	-106↑58.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance